Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of mirtazapine on quality of life in breast cancer patients
IRCT20210425051075N1Phase 3Completed
- Sponsor
- Sabzevar University of Medical Sciences
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of mirtazapine in breast cancer and major depressive disorder (MDD), sponsored by Sabzevar University of Medical Sciences. Started May 2021; status: completed.
02
Drugs
mirtazapine
03
Conditions
breast cancermajor depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT20210425051075N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210425051075N1.